Abstract
A new tetranuclear dinitrosyliron complex [(μ-SC3H4SN)Fe(NO)2]4 (2), each of a Fe center coordinated with two S or two N, was prepared by CO replacement from the reduced precursor (CO)2Fe(NO)2 with 1 equiv of HSC3H4SN (2-mercaptothiazoline) in the presence of O2(g). The structure of 2 is similar to [(Imid-iPr)Fe(NO)2]4 (Imid-iPr = 2-isopropylimidazole) (Hess et al. J Am Chem Soc 133:20426–20434, 2011), and both complexes comprise a quadrilateral plane of irons with corresponding ligands, SC3H4SN− or Imid-iPr−, bridging the edges and two nitrosyl ligands capping the irons at the corners. An additional equiv of SC3H4SN− was added to 2, which results in the mononuclear {Fe(NO)2}9 (SC3H4SN)2Fe(NO) −2 (3), in the manner of N bound-[SC3H4SN]. Reaction of (TMEDA)IFe(NO)2 (TMEDA = tetramethylethylenediamine) and complex 3 leads to the formation of complex 2. Dinuclear complex [(μ-C5H7N2)Fe(NO)2]2 (4) can be synthesized by the ligand displacement of SC3H4SN− to C5H7N2 − (3,5-dimethylpyrazolate) of 2 (Chong et al. Can J Chem 57:3119–3125, 1979). Complexes 2–4 were characterized by IR and UV–Vis. The molecular structures of 2 and 3 were determined by X-ray single crystal diffraction.
Similar content being viewed by others
References
R. Morphy, C. Kay, Z. Rankovic, Drug Discov. Today 9, 641–651 (2004)
K–.K. Lin, S.-C. Wu, K.-M. Hsu, C.-H. Hung, W.-F. Liaw, Y.-M. Wang, Org. Lett. 15, 4242–4245 (2013)
T.D. Bradshaw, S. Wrigley, D.-F. Shi, R.J. Schultz, K.D. Paul, M.F.G. Stevens, Br. J. Cancer 77, 745–752 (1998)
E.A. Jaimes, D. del Castillo, M.S. Rutherford, L. Raij, J. Am. Chem. Soc. 12, 1204–1210 (2001)
G.C.P. May, P.K. Moore, C.P. Page, Br. J. Pharmacol. 102, 759–763 (1991)
Y.P. Tao, T.P. Misko, A.C. Howlette, C. Klein, Development 124, 3587–3595 (1997)
J. MacMicking, Q. Xie, C. Nathan, Annu. Rev. Immunol. 15, 323–350 (1997)
J.A. McCleverty, Chem. Rev. 104, 403–418 (2004)
C. Badorff, B. Fichtlscherer, A. Muelsch, A.M. Zeiher, S. Dimmeler, Nitric Oxide 6, 305–312 (2002)
J.S. Stamler, D.J. Singel, J. Loscalzo, Science 258, 1898–1902 (1992)
J.S. Stamler, Cell 78, 931–936 (1994)
M. Boese, P.I. Mordvintcev, A.F. Vanin, R. Busse, A. Muelsch, J. Biol. Chem. 270, 29244–29249 (1995)
Y. Henry, M. Lepoivre, J.C. Drapier, C. Ducrocq, J.L. Boucher, A. Guissani, FASEB J. 7, 1124–1134 (1993)
R. Radi, J.S. Beckman, K.M. Bush, B.A. Freeman, J. Biol. Chem. 266, 4244–4250 (1991)
A. Mulsch, Drug Res. 44, 408–411 (1994)
A.F. Vanin, P.I. Mordvintcev, S. Hauschildt, A. Muelsch, Biochim. Biophys. Acta Mol. Cell Res. 1177, 37–42 (1993)
E. Cesareo, L.J. Parker, J.Z. Pedersen, M. Nuccetelli, A.P. Mazzetti, A. Pastore, G. Federici, A.M. Caccuri, G. Ricci, J.J. Adams, M.W. Parker, M.J. Lo, Bello. Biol. Chem. 280, 42172–42180 (2005)
A.F. Vanin, Open Conf. Proc. J. 4, 47–53 (2013)
S.M. Aldoshin, K.A. Lyssenko, M.Y. Antipin, N.A. Sanina, V.V. Gritsenko, J. Mol. Struct. 875, 309–315 (2008)
N.A. Sanina, T.N. Rudneva, S.M. Aldoshin, G.V. Shilov, D.V. Kortchagin, Y.M. Shulga, V.M. Martynenko, N.S. Ovanesyan, Inorg. Chim. Acta 359, 570–576 (2006)
O.A. Rakova, N.A. Sanina, S.M. Aldoshin, N.V. Goncharova, G.V. Shilov, Y.M. Shulga, N.S. Ovanesyan, Inorg. Chem. Commun. 6, 145–148 (2003)
N. A.Sanina, T.N. Roudneva, G.V. Shilov, R. Morgunov, N.S. Ovanesyan, S. M. Aldoshin, Dalton Trans. 1703–1706 (2009)
N.A. Sanina, O.A. Rakova, S.M. Aldoshin, G.V. Shilov, Y.M. Shulga, A.V. Kulikov, N.S. Ovanesyan, Mendeleev Commun. 14, 7–8 (2004)
J.L. Hess, C.-H. Hsieh, J.H. Reibenspies, M.Y. Darensbourg, Inorg. Chem. 50, 8541–8552 (2011)
K. Chong, T. Rettiga, L. Torra, N.J. Rotter, Can. J. Chem. 57, 3119–3125 (1979)
J.H. Enemark, R.D. Feltham, Coord. Chem. Rev. 13, 339–406 (1974)
M.-C. Hung, M.-C. Tsai, W.-F. Liaw, Inorg. Chem. 45, 6041–6047 (2006)
M.-L. Tsai, W.-F. Liaw, Inorg. Chem. 45, 6583–6585 (2006)
Z.J. Tonzetich, L.H. Do, S.J. Lippard, J. Am. Chem. Soc. 131, 7964 (2009)
J.L. Hess, C.-H. Hsieh, S.M. Brothers, M.B. Hall, M.Y. Darensbourg, J. Am. Chem. Soc. 133, 20426–20434 (2012)
APEX2, version 2009.7-0; (Bruker AXS, Inc., Madison, 2007)
SAINTPLUS: Program for Reduction of Area Detector Data, version 6.63; (Bruker AXS, Inc., Madison, 2007)
G.M. Sheldrick, SADABS: Program for Absorption Correction of Area Detector Frames (Bruker AXS Inc., Madison, 2001)
G.M. Sheldrick, SHELXS-97: Program for Crystal Structure Solution; Germany (1997)
G.M. Sheldrick, SHELXL-97: Program for Crystal Structure Refinement; Germany (1997)
C.F. Macrae, P.R. Edgington, P. McCabe, E. Pidcock, G.P. Shields, R. Taylor, M. Towler, J. van de Streek, J. Appl. Crytsallogr. 39, 453–457 (2006)
Acknowledgments
We gratefully acknowledge financial support from the National Science Council of Taiwan. The authors thank Dr. Gene-Hsiang Lee for the single-crystal X-ray structural determinations.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, CH., Wang, JH., Huang, JY. et al. A new member of tetranuclear dinitrosyl iron complexes (DNICs) with 2-mercaptothiazoline ligand: synthesis, structure and properties. Res Chem Intermed 40, 2217–2227 (2014). https://doi.org/10.1007/s11164-014-1599-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-014-1599-4